Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,590
  • Shares Outstanding, K 1,430
  • Annual Sales, $ 15,200 K
  • Annual Income, $ -5,850 K
  • 60-Month Beta 1.61
  • Price/Sales 0.63
  • Price/Cash Flow N/A
  • Price/Book 0.66
Trade PRPO with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 45.44%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.00 +11.77%
on 03/22/24
7.00 -4.21%
on 04/01/24
+0.61 (+9.92%)
since 03/15/24
3-Month
5.82 +15.21%
on 02/06/24
7.30 -8.15%
on 01/19/24
+0.63 (+10.28%)
since 01/17/24
52-Week
4.75 +41.11%
on 09/22/23
14.80 -54.70%
on 06/07/23
-7.25 (-51.96%)
since 04/17/23

Most Recent Stories

More News
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development

Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, ThermoFisher, and other distributors ...

PRPO : 6.71 (-0.45%)
Precipio Announces Second Quarter Shareholder Update Call

Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST...

PRPO : 6.71 (-0.45%)
Precipio to distribute HemeScreen® through Fisher Healthcare channel

Agreement Enhances Precipio’s Product Reach to US Laboratories...

PRPO : 6.71 (-0.45%)
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote

Meeting Adjourned, new meeting set for July 5th at 10am EDT...

PRPO : 6.71 (-0.45%)
Keith Meadors Joins Precipio to Lead its Products Division

Seasoned, experienced industry executive with a track record of managing 9-figure revenue sales organizations...

PRPO : 6.71 (-0.45%)
Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe

This Regulatory Approval Opens the Company’s Reach to the European Market...

PRPO : 6.71 (-0.45%)
Precipio Signs First IV-Cell Customer Agreement

Laboratory operating both HemeScreen® & IV-Cell® demonstrates significant cross-sell potential...

PRPO : 6.71 (-0.45%)
Precipio customer American Oncology Network (AON) selected to present HemeScreen® technology case study at Industry leading clinical laboratory conference

NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), is excited to announce its...

PRPO : 6.71 (-0.45%)
Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call

Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST...

PRPO : 6.71 (-0.45%)
Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO

NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl...

PRPO : 6.71 (-0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class...

See More

Key Turning Points

3rd Resistance Point 6.82
2nd Resistance Point 6.76
1st Resistance Point 6.73
Last Price 6.71
1st Support Level 6.65
2nd Support Level 6.59
3rd Support Level 6.56

See More

52-Week High 14.80
Fibonacci 61.8% 10.96
Fibonacci 50% 9.78
Fibonacci 38.2% 8.59
Last Price 6.71
52-Week Low 4.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar